复发转移性宫颈癌的治疗研究进展  

Research Progress on the Treatment of Recurrent and Metastatic Cervical Cancer

作　　者：马宇倩 顾涛[2] 

机构地区：[1]承德医学院研究生学院 [2]秦皇岛市第一医院肿瘤放疗科,河北 秦皇岛

出　　处：《临床个性化医学》2024年第4期2621-2626,共6页Journal of Clinical Personalized Medicine

摘　　要：宫颈癌是全球女性最常见的癌症类型之一,尽管通过标准治疗可达到早期阶段的治愈,获得较长的无病生存期,但仍有部分患者在治疗后期发生复发或转移。然而复发、转移性宫颈癌患者面临着预后差、生存期短等问题,因其既往行手术、放疗或化疗治疗史,故对于复发、转移性宫颈癌的治疗选择方面有一定局限。随着手术、放疗技术的改进和定制治疗方法的采用以及靶向药物、免疫治疗的新兴,为复发、转移性宫颈癌的治疗带来了新方向。现就复发、转移性宫颈癌的治疗研究新进展展开综述。Cervical cancer is one of the most common types of cancer in women worldwide, and although early stage cure with standard treatment provides a long disease-free survival, some patients still develop recurrence or metastasis in the later stage of treatment. However, the patients with recurrent and metastatic cervical cancer are faced with poor prognosis and short survival period, and due to their previous history of surgery, radiotherapy or chemotherapy, the treatment choice of recurrent and metastatic cervical cancer is limited. With the improvement of surgery and radiotherapy technology and the adoption of customized treatment methods and the application of targeted drugs and immune drugs, it brings a new direction for the treatment of recurrent and metastatic cervical cancer. The new progress in the treatment of recurrent and metastatic cervical cancer is reviewed.

关 键 词：复发转移性宫颈癌 治疗进展 放射治疗 全身治疗 

分 类 号：R73[医药卫生—肿瘤]